
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
SynteractHCR, an international contract research organization (CRO) and The GOG Foundation, Inc., a non-profit focused on gynecologic oncology research, signed an agreement to work together on gynecologic oncology clinical studies. The collaboration will offer a streamlined process for drug development companies to improve the timeliness of determining clinical research studies, and facilitate rapid trial execution. The reciprocal relationship has a three-year term.
Read the full release






